| Income Statement |
| Cost of Revenue | 5.44M |
|
| Gross Profit | -5.44M |
| Operating Expenses | 44.62M |
| Research and Development Expense | 9.65M |
| Selling, General and Administrative Expense | 34.17M |
| Operating Income | -50.06M |
| Net Income | -48.29M |
| Net Income Common Stock | -48.29M |
| Net Income Common Stock (USD) | -48.29M |
| Consolidated Income | -48.29M |
| Earnings per Basic Share | -0.54 |
| Earnings per Basic Share (USD) | -0.54 |
| Earnings per Diluted Share | -0.54 |
| Earning Before Interest & Taxes (EBIT) | -48.29M |
| Earning Before Interest & Taxes (USD) | -48.29M |
| Weighted Average Shares | 89.74M |
| Weighted Average Shares Diluted | 89.74M |
| Balance Sheet |
| Cash and Equivalents | 211.67M |
| Cash and Equivalents (USD) | 211.67M |
| Investments | 660.00K |
| Investments Current | 660.00K |
| Trade and Non-Trade Receivables | 632.00K |
| Current Assets | 194.21M |
| Property, Plant & Equipment Net | 53.01M |
| Total Assets | 269.90M |
| Current Liabilities | 4.21M |
| Total Liabilities | 46.10M |
| Accumulated Retained Earnings (Deficit) | -875.02M |
| Shareholders Equity | 223.80M |
| Shareholders Equity (USD) | 223.80M |
| Assets Non-Current | 75.69M |
| Inventory | 1.46M |
| Liabilities Non-Current | 41.90M |
| Trade and Non-Trade Payables | 4.18M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 385.00K |
| Net Cash Flow from Financing | 39.26M |
| Net Cash Flow / Change in Cash & Cash Equivalents | 7.44M |
| Capital Expenditure | -508.00K |
| Issuance (Purchase) of Equity Shares | 43.46M |
| Net Cash Flow from Investing | -508.00K |
| Net Cash Flow from Operations | -31.31M |
| Share Based Compensation | 19.13M |